125 related articles for article (PubMed ID: 36938660)
21. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
[TBL] [Abstract][Full Text] [Related]
22. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
Westcott PM; Halliwill KD; To MD; Rashid M; Rust AG; Keane TM; Delrosario R; Jen KY; Gurley KE; Kemp CJ; Fredlund E; Quigley DA; Adams DJ; Balmain A
Nature; 2015 Jan; 517(7535):489-92. PubMed ID: 25363767
[TBL] [Abstract][Full Text] [Related]
23. Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
Mogensen MB; Rossing M; Østrup O; Larsen PN; Heiberg Engel PJ; Jørgensen LN; Hogdall EV; Eriksen J; Ibsen P; Jess P; Grauslund M; Nielsen HJ; Nielsen FC; Vainer B; Osterlind K
BMC Cancer; 2018 Jul; 18(1):752. PubMed ID: 30029640
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113
[TBL] [Abstract][Full Text] [Related]
25. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.
Bender RP; McGinniss MJ; Esmay P; Velazquez EF; Reimann JD
Mod Pathol; 2013 Oct; 26(10):1320-8. PubMed ID: 23599145
[TBL] [Abstract][Full Text] [Related]
26. Frequent activating HRAS mutations in trichilemmoma.
Tsai JH; Huang WC; Jhuang JY; Jeng YM; Cheng ML; Chiu HY; Kuo KT; Liau JY
Br J Dermatol; 2014 Nov; 171(5):1073-7. PubMed ID: 24890286
[TBL] [Abstract][Full Text] [Related]
27. Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus.
Levinsohn JL; Tian LC; Boyden LM; McNiff JM; Narayan D; Loring ES; Yun D; Sugarman JL; Overton JD; Mane SM; Lifton RP; Paller AS; Wagner AM; Antaya RJ; Choate KA
J Invest Dermatol; 2013 Mar; 133(3):827-830. PubMed ID: 23096712
[No Abstract] [Full Text] [Related]
28. A Case of Apocrine Carcinoma Arising in a Sebaceous Naevus: Detection of HRAS G13R Mutation.
Katsuie S; Kiniwa Y; Mikoshiba A; Goto K; Okuyama R
Acta Derm Venereol; 2022 Apr; 102():adv00697. PubMed ID: 35393630
[No Abstract] [Full Text] [Related]
29. Comparative genomics of high grade neuroendocrine carcinoma of the cervix.
Hillman RT; Cardnell R; Fujimoto J; Lee WC; Zhang J; Byers LA; Ramalingam P; Leitao M; Swisher E; Futreal PA; Frumovitz M
PLoS One; 2020; 15(6):e0234505. PubMed ID: 32544169
[TBL] [Abstract][Full Text] [Related]
30. Keratinocytic epidermal nevi are associated with mosaic RAS mutations.
Hafner C; Toll A; Gantner S; Mauerer A; Lurkin I; Acquadro F; Fernández-Casado A; Zwarthoff EC; Dietmaier W; Baselga E; Parera E; Vicente A; Casanova A; Cigudosa J; Mentzel T; Pujol RM; Landthaler M; Real FX
J Med Genet; 2012 Apr; 49(4):249-53. PubMed ID: 22499344
[TBL] [Abstract][Full Text] [Related]
31. Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi.
Igawa S; Honma M; Minami-Hori M; Tsuchida E; Iizuka H; Ishida-Yamamoto A
J Dermatol; 2016 Jan; 43(1):103-4. PubMed ID: 26498739
[No Abstract] [Full Text] [Related]
32. Identification of a recurrent mosaic
Green TE; MacGregor D; Carden SM; Harris RV; Hewitt CA; Berkovic SF; Penington AJ; Scheffer IE; Hildebrand MS
Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34649968
[TBL] [Abstract][Full Text] [Related]
33. Genomic and prognostic heterogeneity among RAS/BRAF
Berg KCG; Brunsell TH; Sveen A; Alagaratnam S; Bjørnslett M; Hektoen M; Brudvik KW; Røsok BI; Bjørnbeth BA; Nesbakken A; Lothe RA
Mol Oncol; 2021 Apr; 15(4):830-845. PubMed ID: 33325154
[TBL] [Abstract][Full Text] [Related]
34. Extensive genomic analysis in patients with
Jacobsen IC; Spanggaard I; Højgaard M; Belcaid L; Qvortrup C; Yde CW; Schmidt AY; Nielsen FC; Willemoe GL; Dam MS; Lassen U; Staal Rohrberg K
Acta Oncol; 2022 Dec; 61(12):1499-1506. PubMed ID: 36529989
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.
Shern JF; Chen L; Chmielecki J; Wei JS; Patidar R; Rosenberg M; Ambrogio L; Auclair D; Wang J; Song YK; Tolman C; Hurd L; Liao H; Zhang S; Bogen D; Brohl AS; Sindiri S; Catchpoole D; Badgett T; Getz G; Mora J; Anderson JR; Skapek SX; Barr FG; Meyerson M; Hawkins DS; Khan J
Cancer Discov; 2014 Feb; 4(2):216-31. PubMed ID: 24436047
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas.
Pareja F; Toss MS; Geyer FC; da Silva EM; Vahdatinia M; Sebastiao APM; Selenica P; Szatrowski A; Edelweiss M; Wen HY; Mihai R; Varga Z; Foschini MP; Rubin BP; Ellis IO; Chandarlapaty S; Jungbluth AA; Brogi E; Weigelt B; Reis-Filho JS; Rakha EA
Histopathology; 2020 May; 76(6):865-874. PubMed ID: 31887226
[TBL] [Abstract][Full Text] [Related]
37. No evidence of deregulated patched-hedgehog signaling pathway in trichoblastomas and other tumors arising within nevus sebaceous.
Takata M; Tojo M; Hatta N; Ohara K; Yamada M; Takehara K
J Invest Dermatol; 2001 Dec; 117(6):1666-70. PubMed ID: 11886539
[TBL] [Abstract][Full Text] [Related]
38. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
[TBL] [Abstract][Full Text] [Related]
39. The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers.
Barrett MT; Lenkiewicz E; Malasi S; Basu A; Yearley JH; Annamalai L; McCullough AE; Kosiorek HE; Narang P; Wilson Sayres MA; Chen M; Anderson KS; Pockaj BA
Breast Cancer Res; 2018 Jul; 20(1):71. PubMed ID: 29996881
[TBL] [Abstract][Full Text] [Related]
40. Congenital linear unilateral basal cell nevus: a case report with patched gene molecular studies.
Brailey LL; Davis T; Kolker SE; Murry TC; Thomas D; Bale AE; Ruhoy SM
J Cutan Pathol; 2007 Jan; 34(1):65-70. PubMed ID: 17214858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
